Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
Conditions
Neurofibromatosis 1 · Plexiform Neurofibroma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Childrens of Alabama, Birmingham, Alabama, United States
Contact: Principal Investigator (Girish Dhall, MD)Laura Katie Metrock, MD (Sub-investigator)Children's Hospital of Los Angeles, Los Angeles, California, United States
Contact: Principal Investigator (Tena Rosser, MD)Nathan Robison, MD (Sub-investigator)Stanford University, Palo Alto, California, United States
Contact: Principal Investigator (Cynthia Campen, MD)Children's National Hospital, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Benjamin Siegel, MD)Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Miriam Bornhorst, MD)University of Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (James Tonsgard, MD)Riley Hospital for Children/Indiana University, Indianapolis, Indiana, United States
Contact: Principal Investigator (Steven Rhodes, MD, PhD)Johns Hopkins University, Baltimore, Maryland, United States
Contact: Principal Investigator (Jaishri Blakeley, MD)National Cancer Institute/ National Institutes of Health, Bethesda, Maryland, United States
Contact: Principal Investigator (Brigitte Widemann, MD)Boston Children's Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Nicole Ullrich, MD, PhD)Mayo Clinic, Rochester, Minnesota, United States
Contact: Principal Investigator (Radhika Dhamija, MBBS)Washington University - St. Louis, St Louis, Missouri, United States
Contact: Principal Investigator (Amy Armstrong, MD)Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Study coordinator (Lori Backus) · Peter.deBlank@cchmc.org; lori.backus@cchmc.org · 513-517-2068Andrea Gross, MD (Sub-investigator)Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Michael Fisher, MD)University of Texas, Southwestern, Dallas, Texas, United States
Contact: Study coordinator (Laura Klesse, MD, PhD) · NFCMCUT@groups.utsouthwestern.edu · (214) 456-2382Contact: Principal Investigator (Laura Klesse, MD, PhD)